Related content

Bevacizumab versus ranibizumab in the treatment of exudative age-related macular degeneration

By Gamulescu Maria-Andreea   Radeck Viola   Lustinger Bruno   Fink Bianca   Helbig Horst  

International Ophthalmology, Vol. 30, Iss. 3, 2010-06 ,pp. : 261-266

Springer Publishing Company

Access to resources Recommend Favorite

Retinal pigment epithelial tear after intravitreal ranibizumab for subfoveal CNV secondary to AMD

By Apte Rajendra  

International Ophthalmology, Vol. 27, Iss. 1, 2007-02 ,pp. : 59-61

Springer Publishing Company

Access to resources Recommend Favorite

Predictive value of VEGF A and VEGFR2 polymorphisms in the response to intravitreal ranibizumab treatment for wet AMD

By Cruz-Gonzalez Fernando   Cabrillo-Estévez Lucía   López-Valverde Gloria   Cieza-Borrella Clara   Hernández-Galilea Emiliano   González-Sarmiento Rogelio  

Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 252, Iss. 3, 2014-03 ,pp. : 469-475

Springer Publishing Company

Access to resources Recommend Favorite

ISCEV standard for clinical pattern electroretinography—2007 update

By Holder Graham   Brigell Mitchell   Hawlina Marko   Meigen Thomas     Bach Michael  

Documenta Ophthalmologica, Vol. 114, Iss. 3, 2007-05 ,pp. : 111-116

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of treatment with ranibizumab in patients with wet age-related macular degeneration in routine clinical care: data from the COMPASS health services research

By Wolf Armin   Kampik Anselm  

Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 252, Iss. 4, 2014-04 ,pp. : 647-655

Springer Publishing Company

Access to resources Recommend Favorite